Project Grant W81XWH2210918
Award Date
9/30/22
Completion Date
9/29/24
Dollars Obligated
$184K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
This $249,700 Project Grant was awarded by the Defense Health Agency to Memorial University of Newfoundland to support an investigation and therapeutic targeting of metabolic pathways in microglia for efficient remyelination in multiple sclerosis. The funding is provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. The two-year...
The Department of the Army Medical Command awarded a $3,246,800 project grant to Duke University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop resorbable poly(ester urea) films for sustained delivery of meloxicam and bupivacaine to manage pain in critical combat casualty environments. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
The Defense Health Agency awarded a $1,397,266 project grant to The University of Queensland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2023 through February 28, 2026 to develop peptide inhibitors targeting sodium channels for the treatment of Amyotrophic Lateral Sclerosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of the Army Medical Command has awarded a $1,577,505 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Trustees of the University of Pennsylvania to develop a next-generation mRNA-LNP therapy to allow gluten tolerance in celiac disease. The award period runs from April 15, 2025 to April 14, 2029. This research, conducted by the university's Clinical Practices division, aims to correct specific aims outlined in the award document to...
The Department of the Army Medical Command awarded a $777,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the University of Wisconsin - Madison. The 3-year grant, effective June 1, 2025 through May 31, 2028, will support multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. This research aims to transform healthcare for military service members and the broader public by advancing disease prevention, diagnosis,...
The Department of the Army Medical Command awarded Duke University a $1,601,314 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2025 to develop monoclonal antibody-based therapeutics for targeting matrix metalloproteinases and diabetic neuropathy. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The Defense Health Agency awarded a $5,099,737 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to 149 Bio LLC, located in Miami, Florida. The grant supports the development of a novel myeloid-targeted therapeutic for treating glomerular diseases. The four-year project, which commenced on July 1, 2025 and is scheduled for completion on June 30, 2029, aims to advance research and transformative healthcare solutions for military service members and the...
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
The Department of the Army Medical Command awarded a $466,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Washington University in University City, Missouri. The grant, titled "Leveraging the Ovarian Tumor Microenvironment for Early Detection Strategies", will fund research focused on transforming healthcare for military service members and the broader public through advanced biomedical investigations. The award period runs from August...